Cargando…

Integrase inhibitors: Why do we need a new drug class for HIV therapy?

Detalles Bibliográficos
Autor principal:	Rockstroh, Jürgen Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516821/ https://www.ncbi.nlm.nih.gov/pubmed/19959410 http://dx.doi.org/10.1186/2047-783X-14-S3-1

Ejemplares similares

Raltegravir: first in class HIV integrase inhibitor
por: Temesgen, Zelalem, et al.
Publicado: (2008)

A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
por: Sharma, Amit, et al.
Publicado: (2014)

Old versus New: Why Do We Need New Antiepileptic Drugs?
por: Lee, Sang Kun
Publicado: (2014)

Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
por: Richter, Patricia, et al.
Publicado: (2022)

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance
por: Wainberg, Mark A.
Publicado: (2012)

Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013)

Why do we need a…Journal?
por: Gopikrishna, Velayutham
Publicado: (2009)

Why do we need Cases Journal?
por: Smith, Richard
Publicado: (2008)

Why do we need male contraceptives?
por: Cheng, C Yan, et al.
Publicado: (2013)

Lifestyle Medicine: Why Do We Need It?
por: Pijl, Hanno
Publicado: (2018)

Why Do We Need Royal Colleges?
por: Adams, Aileen K
Publicado: (1999)

HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases
por: Zhao, Xue Zhi, et al.
Publicado: (2016)

HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants
por: Smith, Steven J., et al.
Publicado: (2021)

Why do we Need Quality Articles, What are we Going to do With?
por: Mueen Ahmed, KK
Publicado: (2011)

Why do we need a new journal in autoimmunity?
por: D'Cruz, David, et al.
Publicado: (2004)

Why do we need a new journal now?
por: Hotta, Nigishi
Publicado: (2010)

Why do we need improved mobility technology?
por: Boninger, Michael L, et al.
Publicado: (2012)

What is vitamin A and why do we need it?
por: Gilbert, Clare
Publicado: (2013)

Why We Do Need Another Medical Journal…
por: Malbrain, Manu L. N. G.
Publicado: (2013)

Why do we need pharmacists in pharmacovigilance systems?
por: Toklu, Hale Z., et al.
Publicado: (2016)

Why do we need to revisit the Cold War?
por: Li, Wei
Publicado: (2020)

Why Do We Need To Diversify the Microbial Sciences?
por: Torres, Alfredo G.
Publicado: (2021)

Why do we need agent-based macroeconomics?
por: Cincotti, Silvano, et al.
Publicado: (2022)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
por: Smith, Steven J., et al.
Publicado: (2021)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?
por: Youdim, Moussa B. H.
Publicado: (2010)

Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
por: Rhee, Soo-Yon, et al.
Publicado: (2008)

Multiple choices for HIV therapy with integrase strand transfer inhibitors
por: Raffi, Francois, et al.
Publicado: (2012)

Review of tipranavir in the treatment of drug-resistant HIV
por: Streeck, Hendrik, et al.
Publicado: (2007)

Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
por: Hutapea, Hotma Martogi Lorensi, et al.
Publicado: (2018)

Why do we still need participatory technology assessment?
por: Hennen, Leonhard
Publicado: (2012)

HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa
por: Gottlieb, Geoffrey S., et al.
Publicado: (2011)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
por: Koneru, Pratibha C, et al.
Publicado: (2019)

Patterns of resistance development with integrase inhibitors in HIV
por: Mbisa, Jean L, et al.
Publicado: (2011)

Update on Adverse Effects of HIV Integrase Inhibitors
por: Kolakowska, Agnieszka, et al.
Publicado: (2019)

Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
por: Ji, Hezhao, et al.
Publicado: (2018)

Guideline-based management of male infertility: Why do we need it?
por: Trost, Landon W., et al.
Publicado: (2011)

The Asian Nuclear Medicine Board (ANMB); Why Do We Need It?
por: Durr-e-Sabih,
Publicado: (2013)

WHY DO WE NEED AN INTERNATIONAL CONVENTION ON THE RIGHTS OF OLDER PEOPLE?
por: Marumoto, Mika
Publicado: (2019)

Why do we need better omics in the breast cancer care?
por: Gertych, Arkadiusz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qe6fqiu0uevl81574h394l4um6